FTLF vs NAGE: stock comparison and AI forecast
Fitlife Brands, Inc. (FTLF) and Niagen Bioscience, Inc. (NAGE) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
FTLF Fitlife Brands, Inc.
- Price
- $8.00 -16.3% · 6M
- Market Cap
- $75M
- P/E Ratio
- 12.3x
- Size
- small-cap
- AI Forecast
NAGE Niagen Bioscience, Inc.
- Price
- $2.07 -50.6% · 6M
- Market Cap
- $164M
- P/E Ratio
- 14.8x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- NAGE is 2.2 times larger than FTLF by market capitalization ($164M against $75M).
- FTLF trades at 12.3 times trailing earnings, NAGE at 14.8 times.
- Over the last six months FTLF returned -16.3% and NAGE -50.6%.
- NAGE turns 8.4% of its revenue into net income, against 6.2% for FTLF.
- FTLF carries 1.17 times debt per unit of equity, against 0.31 times for NAGE.
- Both companies share the SEC industry classification Medicinal Chemicals & Botanical Products.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | FTLF | NAGE |
|---|---|---|
| Market Cap | $75M | $164M |
| P/E Ratio | 12.31x | 14.78x |
| P/B Ratio | 1.59x | 1.97x |
| EPS | $0.65 | $0.14 |
| Book Value/Share | $5.04 | $1.05 |
| Revenue/Share | $10.78 | $1.55 |
| FCF/Share | $1.07 | – |
Profitability & Margins
| Metric | FTLF | NAGE |
|---|---|---|
| ROE | 13.2% | 12.3% |
| ROA | 6.1% | 9.4% |
| ROIC | 13.5% | 5.2% |
| Gross Margin | 36.5% | 63.9% |
| Operating Margin | 10.9% | 3.9% |
| Net Margin | 6.2% | 8.4% |
| EBT Margin | 8.1% | 9.0% |
| Tax Rate | 23.7% | 7.4% |
Financial Health
| Metric | FTLF | NAGE |
|---|---|---|
| Current Ratio | 1.46x | 5.93x |
| Quick Ratio | 0.45x | 4.71x |
| D/E Ratio | 1.17x | 0.31x |
| Financial Leverage | 2.17x | 1.31x |
| Interest Coverage | 5.2x | 4086.0x |
| Working Capital | $10M | $83M |
Cash Flow
| Metric | FTLF | NAGE |
|---|---|---|
| Operating Cash Flow | $10M | $5M |
| Free Cash Flow | $10M | – |
| Capital Spending | -$10K | – |
| OCF Growth YoY | 53.8% | -77.2% |
| FCF Growth YoY | 54.2% | – |
| FCF/Sales | 9.9% | – |
| CapEx/Sales | 0.0% | – |
Operational Efficiency
| Metric | FTLF | NAGE |
|---|---|---|
| Asset Turnover | 0.99x | 1.13x |
| Receivables Turnover | 14.5x | 17.9x |
| Inventory Turnover | 3.0x | 2.1x |
| Fixed Assets Turnover | 1298.3x | 100.6x |
| Days Sales Outstanding | 25 days | 20 days |
| Days Inventory | 120 days | 170 days |
| Payables Period | 38 days | 95 days |
| Cash Conversion Cycle | 107 days | 95 days |
Income Statement
| Metric | FTLF | NAGE |
|---|---|---|
| Total Revenue | $101M | $122M |
| Operating Income | $11M | $5M |
| Net Income | $6M | $10M |
| R&D Expense | – | $6M |
| SG&A Expense | $19M | $41M |
| Cost of Goods Sold | $64M | $44M |
Dividend & Shareholder Information
| Metric | FTLF | NAGE |
|---|---|---|
| Shares Outstanding | 9M | 79M |
| Net Income Growth | -21.7% | -49.9% |
| EPS Growth | -21.2% | 0.0% |
FTLF vs NAGE: stock comparison and AI forecast
Which is bigger, FTLF or NAGE?
NAGE is 2.2 times larger than FTLF by market capitalization ($164M against $75M).
Which is cheaper on earnings, FTLF or NAGE?
FTLF trades at 12.3 times trailing earnings, NAGE at 14.8 times.
Which stock performed better over the last six months, FTLF or NAGE?
Over the last six months FTLF returned -16.3% and NAGE -50.6%.
Which one does Intratio's AI model rank higher, FTLF or NAGE?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.